Analysis of the cost-effectiveness of surfactant treatment (Curosurf®) in respiratory distress syndrome therapy in preterm infants: early treatment compared to late treatment

Table 2 Endpoint of the clinical study in early and late treatment groups

	*Early* treatment	*Late* treatment	P
	(n = 33)	(n = 27)
MV and/or death < 7 days, number (%)	7 (21)	17 (63)	0.0013
MV and/or death prior to discharge, number (%)	9 (27)	19 (70)	0.004
MV prior to discharge, number (%)	8 (25)	17 (68)	0.005
a/APO₂ after 6 hours, mean ± SD	0.48 ± 0.18	0.36 ± 0.18	0.02
Patent ductus arteriosus, number (%)	10 (30)	16 (59)	0.02

ISSN: 1824-7288